Result : 310

Diagnostic approach for metabolic dysfunction associated steatotic liver disease

Metabolic dysfunction associated steatotic liver disease (MASLD) is a systemic disease affecting the liver. The diagnostic approach consists of the identification of hepatic steatosis, the...
 Lucia Parlati, Charlotte Mouliade, Stanislas Pol. September 2026, page 19

FIB-4: a simple blood test to identify patients at risk of liver complications

 Jérôme Boursier, Frédéric Oberti. September 2026, page 24

Current and future medical treatments for metabolic dysfunction-associated steatohepatitis

Drug treatment of metabolic dysfunction-associated steatotic liver disease (MASLD) is undergoing a revolution. The fight against cardiovascular risk factors, the optimization of the treatment of...
 Rodolphe Anty, Marwin A Farrugia. September 2026, page 26

The role of bariatric surgery and endoscopy in the management of MASLD

The epidemic of metabolic dysfunction-associated steatotic liver disease (MASLD), amplified by shifting dietary habits and increasing sedentary lifestyles, has elevated metabolic...
 Nawel Chouraqui, Guillaume Lassailly. September 2026, page 36

Steatosis and steatohepatitis: a risk factor for complications after liver resection

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its inflammatory form, metabolic dysfunction-associated steatohepatitis (MASH), have become common clinical conditions in...
 Karim Boudjema, Fabien Robin, Heithem Jeddou, Pauline Houssel-Debry. September 2026, page 40

Metabolic dysfunction-associated steatotic liver diseases: 10 key messages

 Catherine Buffet. September 2026, page 45

Acquired hemophilia A

 Louis Hebraud, Olivier Fain, Ambroise Le Pogam. September 2026, page 48

Koenen's tumor

 Matthieu Bellakehal, Arthur Lallier. September 2026, page 51

Living with… a stroke

 Thomas de Broucker. September 2026, page 54

Inflammatory response

 Sylvain Audia, Guillaume Brenac, Bernard Bonnotte. September 2026, page 59